150 related articles for article (PubMed ID: 24566579)
1. Acneiform eruption due to vitamin B12: a problem still unsolved.
Bettoli V; Zauli S; Montis A; Ruina G; Virgili A
G Ital Dermatol Venereol; 2014 Feb; 149(1):153-5. PubMed ID: 24566579
[No Abstract] [Full Text] [Related]
2. Efficacy of clindamycin phosphate and benzoyl peroxide gel (DUAC(®) ) in the treatment of EGFR inhibitors-associated acneiform eruption.
Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP
J Eur Acad Dermatol Venereol; 2016 Aug; 30(8):1436-8. PubMed ID: 26290481
[No Abstract] [Full Text] [Related]
3. Efficacy, tolerability and impact on quality of life of clindamycin phosphate and benzoyl peroxide for the treatment of cetuximab-associated acneiform eruption in patients with metastatic colorectal cancer.
Vaccaro M; Guarneri F; Borgia F; Pollicino A; Altavilla G; Cannavò SP
J Dermatolog Treat; 2016; 27(2):148-52. PubMed ID: 26313697
[TBL] [Abstract][Full Text] [Related]
4. Vitamin B12-induced acneiform eruption.
Balta I; Ozuguz P
Cutan Ocul Toxicol; 2014 Jun; 33(2):94-5. PubMed ID: 23815241
[TBL] [Abstract][Full Text] [Related]
5. Papulopustular acneiform eruptions resulting from trastuzumab, a HER2 inhibitor.
Sheu J; Hawryluk EB; Litsas G; Thakuria M; LeBoeuf NR
Clin Breast Cancer; 2015 Feb; 15(1):e77-81. PubMed ID: 25445421
[No Abstract] [Full Text] [Related]
6. Acneiform eruptions caused by vitamin B12: A report of five cases and review of the literature.
Veraldi S; Benardon S; Diani M; Barbareschi M
J Cosmet Dermatol; 2018 Feb; 17(1):112-115. PubMed ID: 28594082
[TBL] [Abstract][Full Text] [Related]
7. Acneiform eruption in a 5-year-old due to vitamin B12 supplementation.
Aalfs AS; Scholvinck LH; Horváth B
Eur J Dermatol; 2013; 23(5):726-7. PubMed ID: 24125859
[No Abstract] [Full Text] [Related]
8. Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy.
Mahendran A; Wong XL; Kao S; Sebaratnam DF
Photodermatol Photoimmunol Photomed; 2019 May; 35(3):190-192. PubMed ID: 30554437
[No Abstract] [Full Text] [Related]
9. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
[TBL] [Abstract][Full Text] [Related]
10. The tolerability profile of clindamycin 1%/benzoyl peroxide 5% gel vs. adapalene 0.1%/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study.
Gonzalez P; Vila R; Cirigliano M
J Cosmet Dermatol; 2012 Dec; 11(4):251-60. PubMed ID: 23174047
[TBL] [Abstract][Full Text] [Related]
11. Topical treatment for the inflamed lesion in acne, rosacea, and pseudofolliculitis barbae.
Leyden JJ
Cutis; 2004 Jun; 73(6 Suppl):4-5. PubMed ID: 15228127
[No Abstract] [Full Text] [Related]
12. Combination therapy with adapalene-benzoyl peroxide and oral lymecycline in the treatment of moderate to severe acne vulgaris: a multicentre, randomized, double-blind controlled study.
Dréno B; Kaufmann R; Talarico S; Torres Lozada V; Rodríguez-Castellanos MA; Gómez-Flores M; De Maubeuge J; Berg M; Foley P; Sysa-Jedrzejowska A; Kerrouche N; Paliargues F; Bettoli V
Br J Dermatol; 2011 Aug; 165(2):383-90. PubMed ID: 21495995
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus-induced acneiform eruption.
Kunzle N; Venetz JP; Pascual M; Panizzon RG; Laffitte E
Dermatology; 2005; 211(4):366-9. PubMed ID: 16286750
[TBL] [Abstract][Full Text] [Related]
14. Prospective, open-label, comparative study of clindamycin 1%/benzoyl peroxide 5% gel with adapalene 0.1% gel in Asian acne patients: efficacy and tolerability.
Ko HC; Song M; Seo SH; Oh CK; Kwon KS; Kim MB
J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):245-50. PubMed ID: 19438817
[TBL] [Abstract][Full Text] [Related]
15. Clinical experience results with clindamycin 1% benzoyl peroxide 5% gel (Duac) as monotherapy and in combination.
Bikowski JB
J Drugs Dermatol; 2005; 4(2):164-71. PubMed ID: 15776773
[TBL] [Abstract][Full Text] [Related]
16. Facial acneiform rash associated with sorafenib.
Fleta-Asín B; Vañó-Galván S; Ledo-Rodríguez A; Truchuelo-Díez M; Jaén-Olasolo P
Dermatol Online J; 2009 Apr; 15(4):7. PubMed ID: 19450400
[TBL] [Abstract][Full Text] [Related]
17. Optimizing the use of tazarotene for the treatment of facial acne vulgaris through combination therapy.
Draelos ZD; Tanghetti EA;
Cutis; 2002 Feb; 69(2 Suppl):20-9. PubMed ID: 12095065
[TBL] [Abstract][Full Text] [Related]
18. Acneiform eruption induced by vedolizumab.
Magdaleno-Tapial J; Ferrer-Guillén B; Valenzuela-Oñate C; Esteve-Martínez A
Dermatol Online J; 2018 Oct; 24(10):. PubMed ID: 30677821
[TBL] [Abstract][Full Text] [Related]
19. Study of the efficacy, tolerability, and safety of 2 fixed-dose combination gels in the management of acne vulgaris.
Zouboulis CC; Fischer TC; Wohlrab J; Barnard J; Alió AB
Cutis; 2009 Oct; 84(4):223-9. PubMed ID: 19911678
[TBL] [Abstract][Full Text] [Related]
20. A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris.
Tschen EH; Katz HI; Jones TM; Monroe EW; Kraus SJ; Connolly MA; Levy SF
Cutis; 2001 Feb; 67(2):165-9. PubMed ID: 11236229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
